LMNA心肌病:对心力衰竭临床医生的重要考虑
Karen Flores Rosario1, Ravi Karra1, Kaitlyn Amos1
1Duke University Medical Center, Durham, North Carolina.
Journal of cardiac failure
|September 2, 2023
概括
细膜A/C心肌病 (LMNA-CM) 需要特殊治疗,在成像变化之前有早期的电异常. 早期识别和基因检测对于个性化医学和新疗法至关重要.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 精准医学是一门精准的医学.
背景情况:
- 拉胺蛋白A和C心肌病 (LMNA-CM) 是扩张性心肌病的一个独特的遗传原因,具有独特的预后和治疗影响.
- 这种情况从根本上不同于扩张性心肌病的其他遗传病因.
研究的目的:
- 突出认识到临床发现的重要性,并利用LMNA-CM的基因测试在患有异常性非血清性心肌病的患者中.
- 强调LMNA-CM诊断对患者管理,风险分层和新兴基因疗法的影响.
主要方法:
- 对与LMNA-CM相关的临床表现和诊断发现的审查.
- 讨论心磁共振 (CMR) 在早期检测和风险分层中的作用.
- 强调用于识别LMNA-CM的基因检测.
主要成果:
- LMNA-CM通常在第三到第四个十年表现出高透度.
- 电气异常 (导电障碍,心律失常) 往往是左心室功能障碍的成像证据.
- 心脏MRI可以在早期或无症状阶段揭示特征增强模式,帮助风险评估.
结论:
- 提高对LMNA-CM临床特征和基因检测的认识对于精准医学至关重要.
- 诊断影响管理,风险分层和获得新型基因向疗法的资格.
- 临床医生需要了解LMNA-CM的诊断指标以及遗传性心肌病的正在进行的临床试验.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Cardiomyopathy I: Introduction and Classification
15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15


